HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Understanding Factor V and Blood Clot Risk

Blood clots are a normal and necessary part of healing after injury. They form through a carefully coordinated cascade of proteins that create a stable plug where blood vessels are damaged. Factor V, produced by the F5 gene, is an important protein in this cascade. Certain variations in the F5 gene can change how long Factor V stays active. When Factor V is not turned off promptly, the clotting process can continue longer than needed, increasing the chance of unwanted clots forming inside blood vessels. These clots can travel or grow, leading to conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), or in some cases ischemic stroke.

Why this matters

  • Most people with an F5 variant will never develop a clot, but the variant raises statistical risk.
  • Genetic risk interacts with lifestyle, medications, and other medical conditions to determine overall clotting risk.
  • Knowing your F5 genotype can help you and your healthcare provider make informed choices about prevention and monitoring.

Genetic Interpretations

Two effect alleles (TT) — Increased risk

If your genotype is TT at rs6025, you carry two copies of the effect allele. This genotype is associated with an increased risk of blood clots and ischemic stroke. The variant makes Factor V more resistant to being inactivated by activated protein C, the body’s natural “off switch.” With Factor V active for longer, thrombin production increases and clotting activity is prolonged. That raises the likelihood that clots will form more easily or grow larger than necessary, increasing statistical risk for DVT or PE.

This is a genetic predisposition, not a certainty. Lifestyle changes, risk factor management, and working with your healthcare provider can substantially influence your overall risk.

One effect allele (CT) — Likely increased risk

If your genotype is CT at rs6025, you carry one copy of the effect allele. This variant produces a Factor V protein that is more resistant to inactivation by activated protein C. Factor V therefore remains active longer, increasing thrombin and prolonging clotting. That tends to raise the risk of blood clots such as DVT, PE, and may increase risk for ischemic stroke relative to people without this variant.

As with other genetic risks, the CT genotype indicates increased statistical likelihood but does not mean a clot will occur. Risk can be modified by lifestyle and medical management.

No effect alleles (CC) — Typical risk

If your genotype is CC at rs6025, you carry two copies of the non-effect allele. This is the typical genotype and indicates that your Factor V protein is expected to respond normally to activated protein C. Clots should form when needed for healing and then dissolve appropriately. You do not carry this particular genetic cause of prolonged Factor V activity.

Even without this variant, it remains important to follow healthy habits to reduce clot risk from other causes such as prolonged immobility, smoking, obesity, or certain medications.

Practical steps to reduce clot risk

PlexusDx does not provide medical advice. The information below is educational. Always discuss genetic results and next steps with your healthcare provider before making medical decisions.

Lifestyle and activity

  • Stay active. Regular moderate exercise like walking, cycling, or swimming supports circulation and reduces clot risk.
  • Avoid prolonged immobility. On long flights or car trips, stand and walk every 1 to 2 hours, and do calf muscle exercises while seated.
  • Move regularly at work. If you have a desk job, set a timer to stand and stretch every hour.
  • Quit smoking. Smoking increases clotting tendency and damages blood vessels.
  • Manage body weight. Maintaining a healthy weight lowers pressure on veins and reduces inflammatory risk factors.

Diet and hydration

  • Eat a balanced diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats.
  • Include sources of omega-3 fatty acids such as fatty fish, walnuts, or flaxseed. Omega-3s can support cardiovascular health but should be used under medical guidance if you have clotting risk or take blood thinners.
  • Limit excess alcohol and avoid fad diets that may cause dehydration or rapid weight changes.
  • Stay hydrated. Adequate fluid intake helps keep blood less viscous and reduces clot risk, especially during travel or when exercising.

Supplements and medications

  • Supplements such as omega-3 fatty acids may support heart and vessel health, but they can interact with anticoagulant medications. Talk to your healthcare provider before starting supplements.
  • Do not start, stop, or change doses of prescription medications — especially hormonal contraceptives, hormone replacement therapy, or anticoagulants — without medical advice. Some medications influence clotting risk and may be managed differently in people with F5 variants.
  • If you have a strong personal or family history of clots, your provider may consider blood thinning medications or other preventive strategies in specific situations. This is a clinical decision and must be individualized.

When to talk with your healthcare provider

  • Personal or family history of DVT, PE, or unexplained stroke at a young age.
  • Planned long-distance travel, major surgery, or prolonged immobilization. Your provider may recommend temporary preventive measures.
  • Starting hormonal therapies, pregnancy, or planning pregnancy. Pregnancy raises clot risk and may require special monitoring or interventions.
  • Sudden symptoms such as calf pain or swelling, chest pain, shortness of breath, sudden numbness or weakness, or confusion. These can be signs of DVT, PE, or stroke and need immediate medical attention.

Testing and follow-up

If your genotype suggests increased risk, your healthcare provider may consider additional testing or monitoring depending on your personal and family history. Possible options include coagulation studies, testing for other inherited clotting variants, or referral to a hematologist. Decisions about long-term anticoagulation or preventive therapy depend on overall risk profile, not genetics alone.

Summary

Variations in the F5 gene can change how Factor V is regulated and can raise the statistical risk of blood clots. Genotypes with one or two effect alleles generally increase risk compared with the typical genotype. This information is useful for personalized risk discussions and preventive planning but is not a diagnosis by itself. Lifestyle choices such as staying active, avoiding prolonged immobility, maintaining a healthy weight, staying hydrated, and managing blood pressure and cholesterol help reduce clot risk.

PlexusDx does not provide medical advice. Always consult with your healthcare provider to interpret your genetic results, to evaluate your personal and family medical history, and to decide on appropriate testing, monitoring, or treatment.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:

Frequently Asked Questions About BLOOD CLOTS and F5 rs6025

What does the F5 rs6025 variant mean for my blood clot risk?

The F5 gene helps regulate Factor V, a key clotting protein. The rs6025 variant can make Factor V resist being turned off by activated protein C, which may prolong clotting activity and increase statistical risk for clots in blood vessels, including DVT and PE, and in some cases ischemic stroke. This is a genetic predisposition, not a certainty—your overall risk depends on other factors too.

How do rs6025 genotypes (TT, CT, CC) differ in clot risk?

TT (two effect alleles) is associated with increased risk because Factor V is more resistant to inactivation, leading to prolonged clotting activity. CT (one effect allele) is also associated with likely increased risk, with Factor V remaining active longer than typical. CC (no effect alleles) is the typical genotype, where Factor V is expected to respond normally to activated protein C. Even with increased genetic risk, clots are not guaranteed, and risk can be managed.

What lifestyle and medical steps can help reduce clot risk if I have an F5 variant?

Helpful steps include staying active with regular moderate exercise, avoiding prolonged immobility (especially during travel), moving regularly at work, quitting smoking, maintaining a healthy weight, eating a balanced diet, and staying well hydrated. Be cautious with supplements and do not start, stop, or change medications (including hormonal therapies or anticoagulants) without your healthcare provider. If you have a strong personal/family history, are planning long travel or surgery, are starting pregnancy-related hormonal therapies, or notice sudden symptoms of DVT/PE/stroke, talk to your provider promptly.

What tests can help me learn more about BLOOD CLOTS and F5 rs6025?

The Functional Health Genetic Test delivers over 750 personalized genetic insights across 10 in-depth genetic reports to support whole-body, systems-level health understanding. The Cardiometabolic Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.